Products / Pipeline
Alcover Sirup is approved and distributed by D&A PHARMA in Austria. It is indicated :
- in the treatment of Acute alcohol withdrawal syndrome in case of chronic alcohol abuse and
- as adjuvant in the long-term alcoholic disintoxication therapy under careful medical supervision along with psychotherapy and social rehabilitation measures
Alcover Sirup’s active ingredient is sodium oxybate (SMO)
Our R&D pipeline is focused on the development of innovative Sodium Oxybate Formulations for:
- The maintenance of abstinence in alcohol dependent patients with alcoholic liver diseases (SMO I.R Liver) in the US.
- The treatment of narcolepsy (SMO I.R Narco and SMO M.R Narco)